THE SUPERIORITY OF CCNU IN THE TREATMENT OF ADVANCED HODGKINS-DISEASE - CANCER AND LEUKEMIA GROUP-B STUDY

被引：0

作者：

HANSEN, HH

SELAWRY, OS

PAJAK, TF

SPURR, CL

FALKSON, G

BRUNNER, K

CUTTNER, J

NISSEN, NI

HOLLAND, JF

机构：

[1] UNIV MIAMI,MIAMI,FL 33152

[2] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103

[3] CUNY MT SINAI SCH MED,NEW YORK,NY 10029

[4] HF VERWOERD,PRETORIA,SOUTH AFRICA

[5] STAT OFF,CANC & LEUKEMIA GRP B,SCARSDALE,NY

来源：

CANCER | 1981年 / 47卷 / 01期

关键词：

D O I：

10.1002/1097-0142(19810101)47:1<14::AID-CNCR2820470103>3.0.CO;2-Y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：14 / 18

页数：5

共 18 条

[1] 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (CCNU, NSC-79037) - COMPARISON OF DRUG ADMINISTRATION AT 4-WEEK AND 6-WEEK INTERVALS [J].

BRODER, LE ;

HANSEN, HH .

EUROPEAN JOURNAL OF CANCER, 1973, 9 (02) :147-152

[2]

COOPER MR, 1975, P AM ASSOC CANC RES, V16, P111

[3]

DEVITA VT, 1965, CANCER RES, V25, P1876

[4]

GOLDMAN JM, 1975, LANCET, V2, P1224

[5]

HANSEN HH, 1971, CANCER RES, V31, P223

[6]

KURNICK JE, 1975, CANCER CHEMOTH REP 1, V59, P1147

[7]

LESSNER HE, 1968, CANCER, V22, P451, DOI 10.1002/1097-0142(196808)22:2<451::AID-CNCR2820220224>3.0.CO

[8]

2-Z

[9]

MAURICE P, 1978, CANCER, V41, P1658, DOI 10.1002/1097-0142(197805)41:5<1658::AID-CNCR2820410502>3.0.CO

[10]

2-I

← 1 2 →